Gilead Sciences, Inc. (GILD) Tops Q2 EPS by 63c; Boosts FY14 Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Gilead Sciences (GILD) PT Raised to $111 at Piper Jaffray Post Q2
July 24, 2014 10:40 AM EDTPiper Jaffray analyst Joshua Schimmer reiterated an Overweight rating and boosted his price target on Gilead Sciences (NASDAQ: GILD) to $111.00 (from $106.00) following better-than-expected Q2 results and outlook.
Schimmer commented, "Yet again, GILD easily surpassed top/bottom line numbers but contracted LT growth... More
Gilead Sciences (GILD) PT Lifted to $165 at BMO Capital on Strong Q2
July 24, 2014 6:40 AM EDTBMO Capital analyst Jim Birchenough, M.D.boosted his price target on Outperform-rated Gilead Sciences (NASDAQ: GILD) to $165.00 (from $120.00) following Q2 results.
Birchenough comments, "With SOVALDI continuing to set sales records on a background of incomplete insurance coverage in the U.S.,... More
About 9,000 Hep C patients have been cured with Sovaldi to date - Gilead (GILD)
July 23, 2014 4:48 PM EDTGilead Sciences (NASDAQ: GILD) said about 9,000 Hep C patients have been cured with Sovaldi to date
... MoreGilead Sciences (GILD) to Resume Trading at 4:25PM ET Following Strong Results
July 23, 2014 4:22 PM EDTGilead Sciences (NASDAQ: GILD) set to resume trading at 4:25PM ET following strong Q2 results and outlook.
... MoreGilead Sciences (GILD) trading halted with news pending
July 23, 2014 4:04 PM EDTGilead Sciences (NASDAQ: GILD) trading halted with news pending.
... More